======= FICD ======= == Gene Information == * **Official Symbol**: FICD * **Official Name**: FIC domain protein adenylyltransferase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11153|11153]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BVA6|Q9BVA6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FICD&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FICD|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620875|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Protein that can both mediate the addition of adenosine 5'-monophosphate (AMP) to specific residues of target proteins (AMPylation), and the removal of the same modification from target proteins (de-AMPylation), depending on the context (By similarity). The side chain of Glu-231 determines which of the two opposing activities (AMPylase or de-AMPylase) will take place (By similarity). Acts as a key regulator of the ERN1/IRE1-mediated unfolded protein response (UPR) by mediating AMPylation or de- AMPylation of HSPA5/BiP (PubMed:25601083). In unstressed cells, acts as an adenylyltransferase by mediating AMPylation of HSPA5/BiP at 'Thr-518', thereby inactivating it (By similarity). In response to endoplasmic reticulum stress, acts as a phosphodiesterase by mediating removal of ATP (de-AMPylation) from HSPA5/BiP at 'Thr-518', leading to restore HSPA5/BiP activity (By similarity). Although it is able to AMPylate RhoA, Rac and Cdc42 Rho GTPases in vitro, Rho GTPases do not constitute physiological substrates (PubMed:19362538, PubMed:25601083). {ECO:0000250|UniProtKB:A0A061I403, ECO:0000269|PubMed:22266942, ECO:0000269|PubMed:25435325, ECO:0000269|PubMed:25601083, ECO:0000305|PubMed:19362538}. |Fic| |protein denucleotidylation| |protein adenylylhydrolase activity| |protein deadenylylation| |protein adenylylation| |protein nucleotidylation| |protein adenylyltransferase activity| |regulation of IRE1-mediated unfolded protein response| |regulation of endoplasmic reticulum unfolded protein response| |Hsp70 protein binding| |negative regulation of GTPase activity| |regulation of response to endoplasmic reticulum stress| |chaperone binding| |integral component of endoplasmic reticulum membrane| |response to unfolded protein| |response to topologically incorrect protein| |response to endoplasmic reticulum stress| |negative regulation of hydrolase activity| |regulation of GTPase activity| |regulation of cellular response to stress| |negative regulation of catalytic activity| |protein homodimerization activity| |identical protein binding| |negative regulation of molecular function| |regulation of hydrolase activity| |regulation of response to stress| |ATP binding| |cellular response to stress| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp538|ZLN024 50μM R08 exp538]]|-1.78| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.72| |[[:results:exp49|NFN1 0.1μM R01 exp49]]|1.9| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|1.95| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11321 * **Expression level (log2 read counts)**: 3.03 {{:chemogenomics:nalm6 dist.png?nolink |}}